207 related articles for article (PubMed ID: 15234858)
1. Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
Martínez E; Milinkovic A; de Lazzari E; Ravasi G; Blanco JL; Larrousse M; Mallolas J; García F; Miró JM; Gatell JM
Lancet; 2004 Jul 3-9; 364(9428):65-7. PubMed ID: 15234858
[TBL] [Abstract][Full Text] [Related]
2. Unexpected drug interactions and adverse events with antiretroviral drugs.
Moyle G; Boffito M
Lancet; 2004 Jul 3-9; 364(9428):8-10. PubMed ID: 15234836
[No Abstract] [Full Text] [Related]
3. Severe toxicity associated with the combination of tenofovir and didanosine: case report and review.
Masiá M; Gutiérrez F; Padilla S; Ramos JM; Pascual J
Int J STD AIDS; 2005 Sep; 16(9):646-8. PubMed ID: 16176639
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir poses risk with didanosine.
AIDS Patient Care STDS; 2003 Jun; 17(6):309. PubMed ID: 12880494
[No Abstract] [Full Text] [Related]
5. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected].
Blanchard JN; Wohlfeiler M; Canas A; King K; Lonergan JT
Clin Infect Dis; 2003 Sep; 37(5):e57-62. PubMed ID: 12942419
[TBL] [Abstract][Full Text] [Related]
6. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
[TBL] [Abstract][Full Text] [Related]
7. Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons.
Young B; Weidle PJ; Baker RK; Armon C; Wood KC; Moorman AC; Holmberg SD;
AIDS Patient Care STDS; 2006 Apr; 20(4):238-44. PubMed ID: 16623622
[TBL] [Abstract][Full Text] [Related]
8. Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment.
Callens S; De Schacht C; Huyst V; Colebunders R
J Infect; 2003 Aug; 47(2):188-9. PubMed ID: 12860159
[No Abstract] [Full Text] [Related]
9. Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and didanosine?
Masiá M; Gutiérrez F; Padilla S; Ramos JM; Pascual J
J Acquir Immune Defic Syndr; 2004 Apr; 35(4):427-8. PubMed ID: 15097160
[No Abstract] [Full Text] [Related]
10. Acute onset of pancreatitis with concomitant use of tenofovir and didanosine.
Kirian MA; Higginson RT; Fulco PP
Ann Pharmacother; 2004 Oct; 38(10):1660-3. PubMed ID: 15340130
[TBL] [Abstract][Full Text] [Related]
11. Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine.
Palacios R; Rivero A; Santos I; Ríos MJ; Castaño M; del Arco A; Santos González J;
HIV Clin Trials; 2010; 11(2):118-20. PubMed ID: 20542848
[No Abstract] [Full Text] [Related]
12. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Checking up on ddI and tenofovir in people with HIV/AIDS.
TreatmentUpdate; 2003; 15(3):4-5. PubMed ID: 17216846
[No Abstract] [Full Text] [Related]
13. Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.
García-Benayas T; Rendón AL; Rodríguez-Novóa S; Barrios A; Maida I; Blanco F; Barreiro P; Rivas P; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2006 Apr; 22(4):333-7. PubMed ID: 16623636
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
[TBL] [Abstract][Full Text] [Related]
15. Should tenofovir ever be used in association with didanosine?
Diaz RS
Braz J Infect Dis; 2005 Dec; 9(6):452-3. PubMed ID: 16410938
[No Abstract] [Full Text] [Related]
16. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir and didanosine: a dangerous liaison.
Waters L; Maitland D; Moyle GJ
AIDS Read; 2005 Aug; 15(8):403-6, 413. PubMed ID: 16110555
[No Abstract] [Full Text] [Related]
18. Tenofovir disoproxil fumarate (Viread).
Porche DJ
J Assoc Nurses AIDS Care; 2002; 13(3):100-2. PubMed ID: 12064015
[TBL] [Abstract][Full Text] [Related]
19. Kidney damage reported in some tenofovir users.
TreatmentUpdate; 2003; 15(2):6-7. PubMed ID: 12693362
[No Abstract] [Full Text] [Related]
20. Tenofovir-related nephrotoxicity in HIV-infected patients.
Barrios A; García-Benayas T; González-Lahoz J; Soriano V
AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
[No Abstract] [Full Text] [Related]
[Next] [New Search]